News

Nigerians Mourn Singer Ifunanya Nwangene, Slam Hospitals Over Lack of Antivenom

Published

on

Quick Summary:
Nigerians express outrage after singer Ifunanya Nwangene dies from a snake bite in Abuja, blaming hospitals for lacking antivenom and condemning systemic healthcare failures.

The death of Ifunanya Nwangene, a 26-year-old aspiring singer, has sparked nationwide outrage and social media backlash over the state of Nigeria’s healthcare system.

Nwangene, who gained recognition after appearing on The Voice Nigeria (2021) and later built a following on TikTok, reportedly died on Saturday after being bitten by a snake at her residence in Abuja.

According to reports, she was rushed to two hospitals but died after both facilities failed to administer antivenom, a situation many Nigerians described as avoidable and tragic.

Public Anger and Systemic Criticism

Social media users lamented that Nwangene’s death only gained attention because of her public profile, noting that similar tragedies occur frequently across the country due to poor hospital preparedness.

Popular online health advocate Aproko Doctor blamed the systemic collapse of healthcare, saying:

He questioned why ‘Echitab’, an antivenom developed for Nigerian snakes, was not available in hospitals, accusing authorities of neglecting basic healthcare needs while focusing on infrastructure projects.

Voices of Concern

Human rights lawyer Dele Farotimi recalled Nigeria’s once-proud medical history, lamenting the decline of public hospitals.

Animal and nature enthusiast Arojinle also criticised the situation, noting that even top hospitals like UCH and Adeoyo State Hospital lack antivenom.

Broader Healthcare Implications

Nwangene’s death has reignited debate about Nigeria’s healthcare priorities, supply chain inefficiencies, and emergency response systems.

Many Nigerians are calling for urgent reforms, including mandatory stocking of antivenoms in hospitals and revitalisation of primary healthcare centres to prevent similar tragedies.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version